Recent

% | $
Quotes you view appear here for quick access.

Calmare Therapeutics Incorporated Message Board

  • Looks like Dr. Lopriinzi is a big part of ASCO:

    Responding to Common Concerns of Patients with Cancer: What's New—In a Nutshell—From Research to Therapeutic Strategies

    Gretchen Genevieve Kimmick, MD, MS—Chair
    Duke University Medical Center
    Charles L. Loprinzi, MD
    Mayo Clinic
    Leslie R. Schover, PhD
    The University of Texas MD Anderson Cancer Center
    Sydney Morss Dy, MD, MSc
    The Johns Hopkins University School of Medicine
    Donna B. Greenberg, MD
    Massachusetts General Hospital
    Atilla Soran, MD, MPH
    Magee-Womens Hospital of the University of Pittsburgh Medical Center

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The Title should have read ASCO: Dr. Loprinzi from the Mayo Clinic is currently doing three studies with Calmare. What's new in therapeutic research? Calmare! This session is Friday afternoon May 31st. Over 30,000 medical professionals from 118 countries attend ASCO.

 
CTTC
0.240.00(0.00%)May 26 12:59 PMEDT